Mechanisms of autoantibody-induced pathology

RJ Ludwig, K Vanhoorelbeke, F Leypoldt… - Frontiers in …, 2017 - frontiersin.org
Autoantibodies are frequently observed in healthy individuals. In a minority of these
individuals, they lead to manifestation of autoimmune diseases, such as rheumatoid arthritis …

Tyrosine kinases in autoimmune and inflammatory skin diseases

KP Szilveszter, T Németh, A Mócsai - Frontiers in immunology, 2019 - frontiersin.org
Tyrosine kinases relay signals from diverse leukocyte antigen receptors, innate immune
receptors, and cytokine receptors, and therefore mediate the recruitment and activation of …

European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology …

E Schmidt, H Rashid, AV Marzano… - Journal of the …, 2021 - Wiley Online Library
This guideline has been initiated by the task force Autoimmune Blistering Diseases of the
European Academy of Dermatology and Venereology, including physicians from all relevant …

Epidermolysis bullosa acquisita: the 2019 update

H Koga, C Prost-Squarcioni, H Iwata… - Frontiers in …, 2019 - frontiersin.org
Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Patients with EBA
suffer from chronic inflammation as well as blistering and scarring of the skin and mucous …

Diagnosis of autoimmune blistering diseases

M Witte, D Zillikens, E Schmidt - Frontiers in medicine, 2018 - frontiersin.org
Autoimmune skin blistering diseases (AIBD) are characterized by autoantibodies that are
directed against structural proteins in the skin and adjacent mucous membranes. Some …

Correlation of serum levels of IgE autoantibodies against BP180 with bullous pemphigoid disease activity

N Van Beek, N Lüttmann, F Huebner, A Recke… - JAMA …, 2017 - jamanetwork.com
Importance Bullous pemphigoid (BP) is by far the most frequent autoimmune blistering
disease. The presence of IgE autoantibodies against the transmembrane protein BP antigen …

[HTML][HTML] IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid

L Chakievska, MM Holtsche, A Künstner, S Goletz… - Journal of …, 2019 - Elsevier
IL-17A has been identified as key regulatory molecule in several autoimmune and chronic
inflammatory diseases followed by the successful use of anti-IL-17 therapy, eg in ankylosing …

Structural proteins of the dermal‐epidermal junction targeted by autoantibodies in pemphigoid diseases

S Goletz, D Zillikens, E Schmidt - Experimental dermatology, 2017 - Wiley Online Library
The dermal‐epidermal junction consists of a network of several interacting structural
proteins that strengthen adhesion and mediate signalling events. This structural network …

The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin

CD Sadik, Y Miyabe, T Sezin, AD Luster - Seminars in immunology, 2018 - Elsevier
The deposition of IgG autoantibodies in peripheral tissues and the subsequent activation of
the complement system, which leads to the accumulation of the anaphylatoxin C5a in these …

BP180 is critical in the autoimmunity of bullous pemphigoid

Y Liu, L Li, Y Xia - Frontiers in immunology, 2017 - frontiersin.org
Bullous pemphigoid (BP) is by far the most common autoimmune blistering dermatosis that
mainly occurs in the elderly. The BP180 is a transmembrane glycoprotein, which is highly …